ARPA-H Grants Exthymic to Build Cost-Effective Cell Therapy Device

ARPA-H funding supports Exthymic’s device project aimed at expanding access and reducing costs for cell-based therapies.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here